To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug
SB-742510 is a semi-synthetic pleuromutilin antibiotic that is being developed for treatment of respiratory infections.
The purpose of this study is to estimate the bioavailability of four different formulations and to evaluate the safety of each of the four formulations
|Study Design:||Time Perspective: Prospective|
|Official Title:||An Open-Label, Randomized, Crossover Study to Estimate the Formulation Effect on the Relative Bioavailability of Single Dose Oral SB-742510 in Healthy Subjects|